{
    "paper_id": "485",
    "score": 5,
    "summary": "In this context, 2-ethylhexan-1-ol is identified as a metabolite that exhibits significantly higher levels in malignant pleural effusions compared to benign ones. This suggests that 2-ethylhexan-1-ol could serve as a potential biomarker for differentiating between malignant and benign pleural effusions, highlighting its relevance in the diagnosis of lung cancers."
}